1. Combined Orbital and Cranial Vessel Wall Magnetic Resonance Imaging for the Assessment of Disease Activity in Giant Cell Arteritis
- Author
-
Rennie L. Rhee, Ryan Rebello, Madhura A. Tamhankar, Shubhasree Banerjee, Fang Liu, Quy Cao, Robert Kurtz, Joshua F. Baker, Zhaoyang Fan, Vatsal Bhatt, Naomi Amudala, Sherry Chou, Rui Liang, Marisa Sanchez, Morgan Burke, Lisa Desiderio, Laurie A. Loevner, Jeffrey S. Morris, Peter A. Merkel, and Jae W. Song
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Objective Acute visual impairment is the most feared complication of giant cell arteritis (GCA) but is challenging to predict. Magnetic resonance imaging (MRI) evaluates orbital pathology not visualized by an ophthalmologic examination. This study combined orbital and cranial vessel wall MRI to assess both orbital and cranial disease activity in patients with GCA, including patients without visual symptoms. Methods Patients with suspected active GCA who underwent orbital and cranial vessel wall MRI were included. In 14 patients, repeat imaging over 12 months assessed sensitivity to change. Clinical diagnosis of ocular or nonocular GCA was determined by a rheumatologist and/or ophthalmologist. A radiologist masked to clinical data scored MRI enhancement of structures. Results Sixty‐four patients with suspected GCA were included: 25 (39%) received a clinical diagnosis of GCA, including 12 (19%) with ocular GCA. Orbital MRI enhancement was observed in 83% of patients with ocular GCA, 38% of patients with nonocular GCA, and 5% of patients with non‐GCA. MRI had strong diagnostic performance for both any GCA and ocular GCA. Combining MRI with a funduscopic examination reached 100% sensitivity for ocular GCA. MRI enhancement significantly decreased after treatment (P
- Published
- 2024
- Full Text
- View/download PDF